Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06566560

The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs

Cost-savings and Environmental Impact Obtained From Redispensing Unused Oral Anticancer Drugs

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
2,500 (estimated)
Sponsor
Radboud University Medical Center · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The goal of this prospective intervention study is to investigate the effectiveness of redispensing unused oral anticancer drugs. The main questions it aims to answer are: * What are the cost-savings of redispensing unused oral anticancer drugs? * What is the environmental impact of redispensing unused oral anticancer drugs? Researchers will compare redispensing unused oral anticancer drugs to the standard practice of disposal. Participants will receive their oral anticancer drugs in a sealed bag with a temperature indicator if needed. They will be asked to return any unused oral anticancer drugs to the pharmacy during their next visit to the hospital.

Conditions

Interventions

TypeNameDescription
OTHERredispensing oral anticancer drugsParticipants will receive oral anticancer drugs according to their regular prescriptions, distributed in the original manufacturer's package. Following the guideline, some oral anticancer drug (i.e. requiring temperature storage up to 25C degrees) will be supplemented with a validated temperature indicator (Timestrip Neo, customer configuration), enclosed with a seal bag. Patients are requested to return unused oral anticancer drugs to the outpatient pharmacy that distributed them. Pharmacy staff will assess the quality of returned oral anticancer drugs, applying the following criteria: 1. the seal bag is unopened 2. the drug package is unopend and undamaged 3. the expiry date is ≥ 3 months 4. the medication has not been stored outside the product label storage claim Oral anticancer drugs that meet all criteria are restocked, and consecutively redispensed to participants visiting the same outpatient pharmacy.

Timeline

Start date
2024-01-10
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2024-08-22
Last updated
2024-08-22

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06566560. Inclusion in this directory is not an endorsement.